WAT - WAT ウォ―タ―ズ （）

Dupont Capital Management Corp trimmed its position in shares of Waters Co. (NYSE:WAT – Get Rating) by 14.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,860 shares of the medical instruments supplier’s stock after selling 326 shares during the quarter. Dupont Capital Management […]

Waters Co. (NYSE:WAT – Get Rating) – Equities research analysts at Zacks Research decreased their Q1 2023 earnings estimates for shares of Waters in a research note issued on Tuesday, March 28th. Zacks Research analyst S. Mete now forecasts that the medical instruments supplier will post earnings per share of $2.58 for the quarter, down […]

News Summary: New Battery Cycler Microcalorimeter Solution collects up to six times more data than other commercially available calorimeters. i Integrated real-time data analysis accelerates validation of battery safety, quality, and performance testing by up to 75%. ii Up to 12 batteries can be tested simultaneously for charge-discharge and thermal testing to design experiments in multiple configurations. PITTCON 2023 — Waters Corporation (NYSE: WAT ) today announced a new Battery Cycler Microcalorimeter Solution from its TA Instruments™ Division for high-resolution characterization of battery cells. The instrument and software combination enables non-destructive testing under real-world operating conditions and significantly reduces experiment time from months to weeks, while providing decisive insights for greater battery efficiency, safety, and stability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230320005271/en/ New Battery Cycler Microcalorimeter Solution from Waters'' TA Instruments Division accelerates validation testing of battery safety, quality, and performance by up to 75%.

Waters Corporation (NYSE:NYSE:WAT) Cowen 43rd Annual Health Care Conference March 6, 2023 9:50 AM ETCompany ParticipantsUdit Batra - President, CEO and DirectorConference Call…

Waters is a very interesting long-term steady growth gem, combining bolt-on dealmaking with organic growth and continued share buybacks. Read more about WAT here.

Mark P Vergnano , Board Member at Waters (NYSE: WAT ), reported a large insider buy on March 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Vergnano purchased 3,185 shares of Waters. The total transaction amounted to $997,927. Waters shares are trading down 2.28% at $303.81 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com

Major players in the proteomics market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc. Major players in the proteomics market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc.

Waters Corporation (NYSE:WAT) Udit Batra Ph.D., Waters’ President and Chief Executive Officer, will participate in a fireside chat at the Cowen Healthcare Conference on Monday, March 6th, 2023 at 9:50AM Eastern Time. A live webcast of the event will be available on Waters’ investor relations website at https://ir.waters.com. A replay of the webcast will be available for 30 days. About

https://www.investing.com/news/pro/waters-corp-pt-raised-to-326-at-deutsche-bank-432SI-3008597

The acquisition of Wyatt Technology, a growing leader in light scattering technology and software solutions, accelerates next phase of Waters’ strategy for growth and value creation through increased exposure in attractive, high-growth adjacent markets The post Waters Corp to acquire Wyatt Technology appeared first on Express Pharma .

In Friday’s session, Waters Corporation (NYSE:WAT) marked $346.66 per share, up from $344.30 in the previous session. While Waters Corporation has overperformed by 0.69%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, WAT fell by -4.16%, with highs and lows ranging from $375.24 to $265.61, whereas […]

If history is any guide, there may be good fortune ahead for shares of Waters (NYSE: WAT ). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions. When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term … Full story available on Benzinga.com

Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation. Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation.

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference on Monday, January 9th, 2023 at 4:30PM Pacific Standard Time / 1:30PM Eastern Standard Time. Interested investors can access the live webcast of the presentation on Waters’ investor relations website at https://ir.waters.com. A replay of the webcast will be available for 30 days. About Waters Corpo

In June 2022, Merck and Agilent Technologies entered into a partnership to further expand Agilent Technologies’ (PAT) portfolio of products. Northbrook, IL 60062 -- ( SBWIRE ) -- 12/15/2022 -- The Global Process Analytical Technology Market by Technology (Spectroscopy, Chromatography), Measurement (On-line, In-line, At-line), Product & Service (Analyzers, Probes, Sensors), End User (Pharmaceutical Manufacturers, CROs, CDMO) - Global Forecast to 2027", The global process analytical technology market is projected to reach USD 6.1 billion by 2027 from USD 3.2 billion in 2022, at a CAGR of 13.8% during the forecast period. Market growth is primarily driven by factors such as government regulations on drug safety, increased R&D spending by pharmaceutical and biopharmaceutical firms, improvements in drug quality, increasing government investments in emerging countries, and technological advancements in analytical devices. However, the high cost of deployment of PAT systems and a shortage of skilled professionals are expected to limit market growth to a certain extent in the coming years.